GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » Short Interest

Shin Nippon Biomedical Laboratories (FRA:YB3) Short Interest


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Shin Nippon Biomedical Laboratories's Short Interest

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories's Short Interest Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Short Interest distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Short Interest falls into.



Shin Nippon Biomedical Laboratories (FRA:YB3) Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (FRA:YB3) Headlines

No Headlines